Ibexx & Intel Investors - ITanium Applications are now being developed, following the success of the initial functional silicon and the porting of alll major operating systems.
"Molecular Simulations Inc. Working with Intel on Chemical R&D Software For Intel's IA-64 Architecture"
This train is starting to ROLL and is picking up STEAM !
Paul
{=========================}
biz.yahoo.com
Friday December 10, 11:22 am Eastern Time
Company Press Release
SOURCE: Pharmacopeia, Inc.
Molecular Simulations Inc. Working with Intel on Chemical R&D Software For Intel's IA-64 Architecture
SAN DIEGO and CAMBRIDGE, United Kingdom, Dec. 10 /PRNewswire/ -- Molecular Simulations Inc. (MSI), a wholly owned subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP - news), today announced plans to work with Intel in developing molecular simulation software for Intel's IA-64 architecture. MSI's industry- leading tools include the DMol3 and CASTEP quantum mechanics codes for accurately predicting the structure and properties of materials.
The latest versions of these software products are being released at this week's annual meeting of MSI's Catalysis & Sorption Consortium -- a group of over thirty commercial and academic research organizations. At the meeting, MSI and Intel are introducing plans to service R&D in the chemicals industry by making MSI software available on Itanium®, Intel's first microprocessor based on IA-64 architecture.
MSI's products are being designed for multi-CPU Itanium based workstations and servers running Microsoft's 64-bit Windows NT operating system. The unique scientific capabilities of MSI codes will be combined with the leap forward in price/performance offered by 64-bit Itanium systems and the accessibility of a platform supported by all leading hardware vendors. MSI will work with Intel to ensure that its simulation products are available coincident with shipments of Itanium processor-based systems.
''MSI's work in this area represents an excellent example of using innovative technology in the field of computational chemistry,'' comments Mr. Anand Chandrasekher, GM of the Workstation Products Group at Intel. ''This collaboration helps us to ensure that researchers in the chemicals industry will be able to apply the power of the IA-64 architecture to practical R&D problems from the day that the Itanium® processor is released.''
''MSI continues to push the boundaries in applying simulation to design chemical products and processes,'' says Dr. Michael R. Stapleton, General Manager of Materials Science at MSI. ''The future addition of IA-64 DMol3 and CASTEP to our product line should provide unprecedented power and scalability to our customers. This development is consistent with our strategy of integrating our tools with industry standard software and hardware architectures.''
Molecular Simulations Inc. (MSI) is a leading provider of simulation and informatics software for design and optimisation of materials and chemical systems. MSI software helps the world's foremost industrial research teams to solve commercially significant problems and accelerate product discovery and development. MSI is a subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP - news).
Except for the historical information contained herein, this statement may contain projections or other forward-looking statements regarding future events or the future financial performance of the Company. Pharmacopeia wishes to caution you that such statements are just predictions and that actual events or results may differ materially. Pharmacopeia refers you to the documents that it files from time to time with the Securities and Exchange Commission, specifically the Company's last filed Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. These documents contain and identify important factors, including risk factors that could cause the actual results to differ materially from those contained in the projections or forward-looking statements.
NOTE: The ''3'' in ''DMol3'' is superscript.
SOURCE: Pharmacopeia, Inc. |
